Company / Debt per Share
Aquestive Therapeutics, Inc. Debt per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$0.49
FY2025
5-year range
$0.49 / $0.82
FY2023-FY2025
Trend
-25.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $0.82 to $0.49 over the past 2 years.
Based on SEC 10-K filings.
0.49 in FY2025.
Improved from $0.82 to $0.49 over the past 2 years.
Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, debt per share decreased 25.0% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.49 | -25.0% |
| FY2024 | $0.66 | -20.0% |
| FY2023 | $0.82 | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026